Page last updated: 2024-10-29

ketamine and Epilepsy Syndromes

ketamine has been researched along with Epilepsy Syndromes in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ioku, T1
Inoue, T1
Kuki, I1
Imai, K1
Yamamoto, A1
Cho, M1
Caputo, D1
Iorio, R1
Vigevano, F1
Fusco, L1

Other Studies

2 other studies available for ketamine and Epilepsy Syndromes

ArticleYear
[A case of febrile infection-related epilepsy syndrome requiring prolonged intensive care management: a trial of intravenous ketamine and intrathecal dexamethasone therapy].
    Rinsho shinkeigaku = Clinical neurology, 2022, Feb-19, Volume: 62, Issue:2

    Topics: Adolescent; Critical Care; Dexamethasone; Drug Resistant Epilepsy; Encephalitis; Epileptic Syndromes

2022
Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2018, Volume: 22, Issue:1

    Topics: Adolescent; Anticonvulsants; Autoantibodies; Drug Resistant Epilepsy; Encephalitis; Epileptic Syndro

2018